Literature DB >> 166093

Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion.

J M Canterbury, L A Bricker, G S Levey, P L Kozlovskis, E Ruiz, J E Zull, E Reiss.   

Abstract

The metabolism of bovine parathyroid hormone (PTH) by the perfused rat liver was studied. Labeled hormone, with or without cold hormone, was infused into the circulating perfusion medium containing various calcium concentrations. Pefusate samples at various time periods after the introduction of PTH into the system were chromatographed on Bio-gel P-10; radioactivity and/or immunoreactivity were measured in eluted fractions. Before the perfusion, all immuno- and radioactivity eluted in a single peak, with an apparent mol wt of 9,500 (peak I). After perfusion for 15 min, two other peaks with approximate mol wt of 7,000 (peak II) and 3,500 (peak III) were discernible. Peak I contained both NH2-terminal and COOH-terminal immunoreactivity and was biologically active at all time periods tested. The relative contribution of NH2-terminal and COOH-terminal immunoreactivity to the total immunoreactivity remained constant in this peak throughout the perfusion. In every respect, peak I had the characteristics of intact hormone. At all times, peak II consisted of only COOH-terminal immunoreactivity and was biologically inactive. At early time periods, peak III contained predominantly NH2-terminal immunoreactivity and was biologically active. With time, the relative contribution of NH2-terminal immunoreactivity decreased strikingly while that of COOH-terminal immunoreactivity increased. The three peaks identified in these experiments were analogous in size, biological activity, and immunological characteristics to those we have previously described for fractionated human hyperparathyroid serum. The rate of metabolism of PTH appeared to be regulated by the calcium concentration in the medium. At a high concentration of calcium (greater than 11 mg/100 ml), PTH metabolism was greatly retarded. At a low concentration of calcium (smaller than 5 mg/100 ml), the rate of metabolism was greatly increased. The physiological significance of our observations on the metabolism of PTH by isolated perfused rat liver is not known. However, since such metabolism results in a biologically active fragment, it is suggested that metabolism of intact hormone may be required before full biological expression is possible.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166093      PMCID: PMC301879          DOI: 10.1172/JCI108043

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Evidence for liver inactivation of parathyroid hormone.

Authors:  R DAVIS; R V TALMAGE
Journal:  Endocrinology       Date:  1960-02       Impact factor: 4.736

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Parathyroid hormone metabolism in man: effect of nephrectomy.

Authors:  R A Melick; T J Martin
Journal:  Clin Sci       Date:  1969-12       Impact factor: 6.124

4.  A radioimmunoassay for parathyroid hormone in man.

Authors:  E Reis; J M Canterbury
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

5.  Immunochemical heterogeneity of parathyroid hormone in plasma.

Authors:  S A Berson; R S Yalow
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

6.  The amino acid sequence of bovine parathyroid hormone I.

Authors:  H D Niall; H Keutmann; R Sauer; M Hogan; B Dawson; G Aurbach; J Potts
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-12

7.  Metabolism of parathyroid hormone. Degradation of 125I-labelled hormone by a kidney enzyme.

Authors:  T J Martin; R A Melick; M de Luise
Journal:  Biochem J       Date:  1969-02       Impact factor: 3.857

8.  Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats.

Authors:  J H Exton; C R Park
Journal:  J Biol Chem       Date:  1967-06-10       Impact factor: 5.157

9.  Parathyroid hormone: secretion and metabolism in vivo.

Authors:  J F Habener; D Powell; T M Murray; G P Mayer; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

10.  Radioimmunoassay of human parathyroid hormone in serum.

Authors:  C D Arnaud; H S Tsao; T Littledike
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  20 in total

Review 1.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Metabolism and biological activity of parathyroid hormone in renal cortical membranes.

Authors:  D Goltzman; A Peytremann; E N Callahan; G V Segre; J T Potts
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

3.  Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate CA++ concentrations.

Authors:  K A Hruska; K Martin; P Mennes; A Greenwalt; C Anderson; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Calcium metabolism.

Authors:  E Reiss
Journal:  West J Med       Date:  1975-12

5.  Selective uptake of the synthetic amino terminal fragment of bovine parathyroid hormone by isolated perfused bone.

Authors:  K J Martin; J J Freitag; M B Conrades; K A Hruska; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

6.  Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake.

Authors:  K Martin; K Hruska; A Greenwalt; S Klahr; E Slatopolsky
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

7.  Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs.

Authors:  A I Jacob; J M Canterbury; G Gavellas; P W Lambert; J J Bourgoignie
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

8.  Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.

Authors:  J M Canterbury; S Lerman; A J Claflin; H Henry; A Norman; E Reiss
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Parathyroid hormone concentration gradients across the human bone marrow.

Authors:  M J Atkinson; H Bodenstein; R D Hesch
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

10.  Analysis of parathyroid hormone and its fragments in rat tissues: chemical identification and microscopical localization.

Authors:  P D'Amour; G V Segre; S I Roth; J T Potts
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.